BKYI vs TLIH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BKYI exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile stability, and lacks an Altman Z-Score, raising unquantified distress risk. The company reports severe profitability issues, including a -67.34% profit margin, -137.69% ROE, and negative earnings across all recent quarters, despite a high gross margin of 78.40%. Revenue has declined 27.7% YoY, and earnings surprises have been consistently negative in the last four quarters, with an average miss of -17.33%. The stock trades at a price-to-book of 0.80, but this is misleading given the company’s deep losses and negative equity. Analysts have a target price of $2.00, but with only one analyst covering the stock and no consensus, this is not reliable.
TLIH presents a classic 'value trap' profile, characterized by a stable Piotroski F-Score of 6/9 and extreme valuation discounts (Current Price $0.25 vs. Graham Number $0.74). While the P/E of 2.50 and ROE of 53.32% appear exceptional, they are overshadowed by a catastrophic 93.3% one-year price decline and a technical trend score of 0/100. Severe liquidity risks are evident with a current ratio of 0.70 and high leverage (Debt/Equity 3.82), suggesting that the market is pricing in a high probability of financial distress despite reported earnings growth.
Compare Another Pair
Related Comparisons
BKYI vs TLIH: Head-to-Head Comparison
This page compares BIO-key International, Inc. (BKYI) and Ten-League International Holdings Limited (TLIH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.